Though the overall prevalence of major depressive disorder (MDD) is estimated to be largely equivalent across racial/ethnic groups, there is a significant disparity in the rate of diagnosis of MDD for many racial/ethnic underserved communities, including Black and Hispanic groups. In addition, amongst those from these communities who do receive a diagnosis, treatment offerings are often limited, with antidepressant therapy as well as psychotherapy offered at lower rates as compared to their non-Hispanic White counterparts. Social determinants / drivers of health play an additional role in these disparate outcomes, as negative drivers of health have been associated with progression to treatment resistant depression (TRD). It is imperative that each member of the multidisciplinary care team works together to address these disparities in order to improve equity in treatment and outcomes for all patients.
In this CMEO BriefCase, expert faculty will utilize case-based learning to illustrate these pervasive disparities through the stories of two patients, Luna and Eralia, while offering strategies to address inequities in the treatment and outcomes of patients with MDD and/or TRD.